3rd Translational Research Conference:
Acute Lymphoblastic Leukaemia
May 19-21, 2023 – Berlin, Germany
#ESHALL2023
Chairs: Jan Cools, Hervé Dombret, Adele Fielding, Mark Litzow
On-demand content available to all for free: CLICK HERE
ABOUT THE CONFERENCE:
Major recent advances in the knowledge of the biological underpinning of acute lymphoblastic leukaemia (ALL) include the comprehensive description of B-cell precursor and T-cell ALL genomic landscapes, the identification of new potentially druggable disease subsets and the discovery of predisposing, preleukaemic events.
At the same time, the clinical management of the disease has improved in both children and adults thanks to the routine monitoring of measurable residual disease (MRD), the administration of intensified risk-adapted chemotherapy, the introduction of targeted therapies and antibodies, and the remarkable efficacy of antibody-drug conjugates (ADCs), bi-specific T-cell engager antibodies (BiTEs) and manufactured chimeric antigen receptor (CAR) T-cells.
This intense research activity has led to major improvements in patient outcome, while also providing important proofs of concept for the treatment of cancer in general. It has also made ALL a fascinating disease to study.
The translational scientific programme of the 3rd Translational Research Conference on Acute Lymphoblastic Leukaemia is designed to provide ample time and opportunities for discussion with global authorities in the field.
SCIENTIFIC TOPICS:
– KMT2A-rearranged ALL
– Advances in Ph-like ALL
– Revisiting specific ALL subsets
– New biological insights in ALL
– Ph-positive ALL
– Therapeutic Challenges in Childhood ALL
– Antibody-based ALL Therapies
– CAR T-cells & Stem Cell Transplantation
– Precision Medicine in ALL
LEARNING OBJECTIVES:
Upon completion of this CME activity, participants should:
– Learn how to optimally diagnose and classify ALL by combining modern diagnosis algorithms and early MRD monitoring for the rapid delivery of the right treatment to the right patient;
– Review conventional therapeutic options with a focus on the role of allogeneic haemopoietic stem cell transplantation;
– Learn how to optimize the management of individual patients on the basis of individual drug metabolism, tolerance and toxicity;
– Acquire improved knowledge of new, emerging targeted or immunologic treatments and understand how they may be combined or how they could eventually replace current conventional treatment options.
THE PROGRAMME WILL INCLUDE:
– Plenary Sessions
– Panel Discussions
– Debates
– Poster Walks
– Meet the Expert Sessions
– Keynote lectures
CLICK HERE to access the final programme.
On-demand content including slide bank and video presentations available to all for free: CLICK HERE
ABSTRACT SUBMISSION IS CLOSED!
Abstracts guidelines:
– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)
– Maximum number of words: 500
– Your abstract will be submitted to the peer review procedure.
The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).
Vienna House Andels’ Berlin Hotel (the conference venue)
In order to help you with your travel planning, a number of rooms have been blocked
at a special rate for you.
To book your accommodation at a preferential rate, please CLICK HERE or call the reservation department under 0049 30 453 053 2200
Please mention ESH Acute Lymphoblastic Leukaemia 2023 on your booking
For group reservation, please contact maude.brunet-lecomte@univ-paris-diderot.fr.
—
Warning!
We have detected scam activity of a company trying to sell accommodation services to the speakers of our conferences. Apparently, they have been collecting information on the speakers from the lists that are made public on our websites.
Please make sure you book your accommodation either via the link(s) provided by ESH on this page, or directly with the hotel or renown booking services platform.
Vienna House Andel’s Berlin
Landsberger Allee 106, 10369 Berlin, Germany
Vienna House Andel’s Berlin is located in the district of Lichtenberg, on the border with Prenzlauer Berg and Friedrichshain.
https://www.viennahouse.com/en/andels-berlin/location.html
With the support of*:
Level 2 Conference Partners
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.
The registration fee for the ESH 3rd Translational Research Conference: Acute Lymphoblastic Leukaemia is:
– 600€ for fully trained
– 300€ for in-training *
– 300€ Allied Health Professionals
– 600€ for Corporate
*A proof will be requested to confirm your status.
This fee includes:
Your seat in the conference will be definitively reserved upon receipt of your fee.
How to proceed :
Please make sure that your Internet browser (Firefox, Internet Explorer, Safari, Google Chrome…) is up-to-date. Using an old version may prevent you from visualising the full website content.
Cancellation policy of registration fee :
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.